Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1400 participants.

Also called NCT05627375

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,400 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05627375
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05627375. Randomized; no masking; primary purpose treatment. Start 2023-08-16 (actual); primary completion 2027-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets
Acronym
BAT-VTE
Condition
Venous Thromboembolic Disease
Intervention (Drug)
Full-dose anticoagulant therapy (AC)
Intervention (Drug)
Antiplatelet therapy (AP)
Lead sponsor
Centre Hospitalier Universitaire de Saint Etienne (class: other)
Collaborator
Ministry of Health, France (class: other government)

Record details

Record id
cardio:ct-nct05627375
Content hash
2c93ed2a8e39b500ca04aa30e32beb7922c89cecdb9e0b0959451b51f9a701a8